T Meyer

966 total citations
16 papers, 666 citations indexed

About

T Meyer is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, T Meyer has authored 16 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Epidemiology and 4 papers in Hepatology. Recurrent topics in T Meyer's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lung Cancer Research Studies (3 papers) and Toxoplasma gondii Research Studies (3 papers). T Meyer is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Lung Cancer Research Studies (3 papers) and Toxoplasma gondii Research Studies (3 papers). T Meyer collaborates with scholars based in United Kingdom, Germany and Italy. T Meyer's co-authors include Dirk Schlüter, M. Deckert‐Schlüter, Kjell Öberg, Andrea Frilling, David C. Metz, James R. Goldenring, Dik J. Kwekkeboom, Marianne Pavel, Wouter W. de Herder and Martin Röllinghoff and has published in prestigious journals such as The Journal of Immunology, Gut and The Lancet Oncology.

In The Last Decade

T Meyer

14 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Meyer United Kingdom 10 321 269 176 159 127 16 666
Bernardina T.F. van der Gun Netherlands 13 218 0.7× 148 0.6× 166 0.9× 302 1.9× 20 0.2× 22 699
Kotaro Miyake Japan 14 328 1.0× 125 0.5× 205 1.2× 342 2.2× 25 0.2× 59 864
María C. Ramello Argentina 15 494 1.5× 156 0.6× 511 2.9× 183 1.2× 19 0.1× 23 918
Lorenzo Pacenti Italy 12 170 0.5× 260 1.0× 74 0.4× 197 1.2× 19 0.1× 24 590
Alice P. Taylor United States 11 82 0.3× 133 0.5× 149 0.8× 162 1.0× 8 0.1× 13 510
Fabiana Rizzo Italy 16 224 0.7× 148 0.6× 498 2.8× 249 1.6× 61 0.5× 29 955
Fengrong Ma China 3 511 1.6× 52 0.2× 605 3.4× 123 0.8× 28 0.2× 4 862
H. Travis Ichikawa United States 7 77 0.2× 72 0.3× 251 1.4× 194 1.2× 12 0.1× 7 474
Nikola Baschuk Australia 14 212 0.7× 187 0.7× 324 1.8× 256 1.6× 8 0.1× 21 739

Countries citing papers authored by T Meyer

Since Specialization
Citations

This map shows the geographic impact of T Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Meyer more than expected).

Fields of papers citing papers by T Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Meyer. The network helps show where T Meyer may publish in the future.

Co-authorship network of co-authors of T Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of T Meyer. A scholar is included among the top collaborators of T Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Meyer. T Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Grimm, Bernd, et al.. (2025). Validity of a wireless instrumented insole (WalkinSense system) for measuring gait metrics. Journal of Experimental Orthopaedics. 12(4). e70438–e70438.
2.
Qin, Shukui, Masashi Kudo, T Meyer, et al.. (2022). LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma. Annals of Oncology. 33. S1402–S1403. 54 indexed citations
3.
Strasser, Simone I., Ghassan K. Abou‐Alfa, Patrick Mollon, et al.. (2019). Quality-adjusted life-years accrued with cabozantinib in patients with advanced hepatocellular carcinoma in the CELESTIAL trial. UCL Discovery (University College London).
4.
5.
Sangro, Bruno, Ignacio Melero, Chiun Hsu, et al.. (2017). Nivolumab in Sorafenib-Naive and -Experienced Patients With Advanced Hepatocellular Carcinoma (HCC): Survival, Hepatic Safety, and Biomarker Assessments in CheckMate 040. UCL Discovery (University College London). 12 indexed citations
6.
Öberg, Kjell, Irvin M. Modlin, Wouter W. de Herder, et al.. (2015). Consensus on biomarkers for neuroendocrine tumour disease. The Lancet Oncology. 16(9). e435–e446. 206 indexed citations
7.
García-Hernández, Jorge, Nicholas G. Martin, Michelle Mullan, et al.. (2014). PTH-093 Chromogranin-a : Can It Predict Radiological Progression In Neuroendocrine Tumours?. Gut. 63(Suppl 1). A251.1–A251. 1 indexed citations
8.
Hemmerle, Teresa, et al.. (2013). The antibody-based targeted delivery of TNF in combination with doxorubicin eradicates sarcomas in mice and confers protective immunity. British Journal of Cancer. 109(5). 1206–1213. 74 indexed citations
9.
Hochhauser, Daniel, T Meyer, Victoria J. Spanswick, et al.. (2009). Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors. Clinical Cancer Research. 15(6). 2140–2147. 62 indexed citations
10.
Strauss, Sandra J., Maria Marples, Mark Napier, et al.. (2003). A phase I (tumour site-specific) study of carboplatin and temozolomide in patients with advanced melanoma. British Journal of Cancer. 89(10). 1901–1905. 6 indexed citations
11.
Schlüter, Dirk, T Meyer, Lai‐Yu Kwok, et al.. (2002). Phenotype and Regulation of Persistent Intracerebral T Cells in Murine Toxoplasma Encephalitis. The Journal of Immunology. 169(1). 315–322. 27 indexed citations
12.
Schlüter, Dirk, T Meyer, Sabine Reiter, et al.. (2001). Regulation of Microglia by CD4+ and CD8+ T Cells: Selective Analysis in CD45‐congenic Normal and Toxoplasma gondii‐infected Bone Marrow Chimeras. Brain Pathology. 11(1). 44–55. 28 indexed citations
13.
14.
Schlüter, Dirk, et al.. (1999). Immune Reactions to Listeria Monocytogenes in the Brain. Immunobiology. 201(2). 188–195. 15 indexed citations
15.
Seliger, Barbara, Alexander Knuth, H. Bernhard, et al.. (1996). Analysis of the major histocompatibility complex class I antigen presentation machinery in normal and malignant renal cells: evidence for deficiencies associated with transformation and progression.. PubMed. 56(8). 1756–60. 97 indexed citations
16.
Göhl, J., T Meyer, Charles D. Haas, A. Altendorf-Hofmann, & Werner Hohenberger. (1996). [Is surgical therapy of distant metastases of malignant melanoma worthwhile?].. PubMed. 113. 122–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bernardina T.F. van der Gun Breakdown of academic impact, for papers by Kotaro Miyake Breakdown of academic impact, for papers by María C. Ramello Breakdown of academic impact, for papers by Lorenzo Pacenti Breakdown of academic impact, for papers by Alice P. Taylor Breakdown of academic impact, for papers by Fabiana Rizzo Breakdown of academic impact, for papers by Fengrong Ma Breakdown of academic impact, for papers by H. Travis Ichikawa Breakdown of academic impact, for papers by Nikola Baschuk
Rankless by CCL
2026